Mechanistically, TSP4 activates the integrin αvβ3/FAK/ERK signaling axis, leading to enhanced LEC migration, which may contribute to lymphangiogenesis and lymphatic metastasis in the BLCA TME. Here, PTK2 is linked to bladder transitional cell carcinoma.